D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RUBY holding history
Rubius Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RUBY overviewAll 13F holders of RUBYFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −117,446−100.0% | Sold out | Holders |
| Q2 2022 | 117,446 | $100.0K | <0.1% | +62,566+114.0% | Added | Holders |
| Q1 2022 | 54,880 | $302.0K | <0.1% | −37,036−40.3% | Reduced | Holders |
| Q4 2021 | 91,916 | $890.0K | <0.1% | −11,278−10.9% | Reduced | Holders |
| Q3 2021 | 103,194 | $1.84M | <0.1% | −26,225−20.3% | Reduced | Holders |
| Q2 2021 | 129,419 | $3.16M | <0.1% | −39,156−23.2% | Reduced | Holders |
| Q1 2021 | 168,575 | $4.47M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.